Changes how long a drug must have been approved before it can be picked for negotiation under the federal Drug Price Negotiation Program. For drugs whose initial negotiated price years are 2026 or 2027, the bill requires at least 7 years since FDA approval; for drugs with initial price years 2028 and later, it requires at least 11 years since approval.